About
Team
Stories
Analysis
Education
Contribute

Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookie Policy

About
Team
Stories
Analysis
Education
Contribute

business

Reuters

9 July 2021

Sweden’s Vitrolife to buy Igenomix in EUR 1.25 billion deal

Swedish medical technology group Vitrolife said on Thursday it would buy reproductive genetic testing services provider Igenomix S.L. in a

share

The News in Brief

Fertility News From Around the Web

People born by donor eggs or sperm will be able to find out biological origins

26 September 2023

I tried to get pregnant for so long – but when it happened I only felt guilt

26 September 2023

Ten years of egg freezing – is it time for re-evaluation?

5 September 2023

British women turn to IVF clinics in Greece and Turkey to avoid higher costs

1 September 2023

Online retailers mislead on ‘egg timer’ fertility test

25 August 2023

Subscribe To Our Newsletter

Get Big Fertility Project updates.

We won't send you spam.
Unsubscribe at any time.

Leave this field empty if you're human:

Research in Brief

Latest Research From Peer Reviewed Journals

How common is natural conception in women who have had a livebirth via assisted reproductive technology? Systematic review and meta-analysis

21 June 2023

Heparin for women with recurrent miscarriage and inherited thrombophilia (ALIFE2): an international open-label, randomised controlled trial

5 June 2023

Effect of dehydroepiandrosterone administration before in vitro fertilization on the live birth rate in poor ovarian responders according to the Bologna criteria: A randomised controlled trial

19 March 2023

What is the optimal GnRH antagonist protocol for ovarian stimulation during ART treatment? A systematic review and network meta-analysis

14 February 2023

Time-to-conception and clinical pregnancy rate with a myo-inositol, probiotics and micronutrient supplement: secondary outcomes of the NiPPeR Randomized Trial

9 February 2023